宝莱特(300246) - 2025 Q3 - 季度财报
BIOLIGHTBIOLIGHT(SZ:300246)2025-10-24 12:15

Financial Performance - The company's operating revenue for Q3 2025 was CNY 269,780,260.93, a decrease of 0.46% compared to the same period last year[5] - The net profit attributable to shareholders was CNY -9,655,087.06, representing a decline of 13.22% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -12,669,138.10, an increase of 19.09% compared to the previous year[5] - The net profit for the reporting period improved to -3,978,292.36, a 64.62% increase compared to -11,245,481.62 from the previous period[10] - The total comprehensive income increased to -2,433,341.98, reflecting a 78.51% improvement from -11,324,034.95[10] - The total profit for the current period is -6,964,537.49, an improvement from -8,696,470.58 in the previous period, reflecting a reduction in losses[23] - The basic earnings per share for the current period is -0.0315, compared to -0.0519 in the previous period, indicating a reduction in losses per share[24] Cash Flow and Assets - Cash flow from operating activities showed a significant increase of 195.54%, totaling CNY 37,761,959.61 year-to-date[5] - The company's cash and cash equivalents increased by 39.00%, reaching CNY 648,299,752.44, primarily due to the recovery of financial products and government subsidies[9] - The cash and cash equivalents at the end of the period rose to 623,435,189.73, a 49.47% increase from 417,084,606.49[11] - The company's cash flow from operating activities showed a significant improvement, with cash and cash equivalents at the end of the period increasing by ¥181,913,596.31[20] - The net cash flow from operating activities is 37,761,959.61, a turnaround from -39,525,496.61 in the previous period, showing a positive cash flow shift[25] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,527,949,433.55, reflecting a growth of 1.17% from the end of the previous year[5] - The total liabilities increased to ¥1,241,059,124.58 from ¥1,207,716,158.57, an increase of 2.7%[21] - The long-term borrowings increased by 52.49% to 277,177,390.88, up from 181,770,000.00[10] - The company recorded a 422.19% increase in current liabilities due to the reclassification of convertible bonds, totaling 247,271,977.40 compared to 47,353,275.53[10] - Non-current assets rose to ¥1,240,182,517.93 from ¥1,165,133,901.52, reflecting a growth of 6.4%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,178, with no preferred shareholders[13] - The largest shareholder, Yan Jinyuan, holds 26.72% of the shares, totaling 70,705,185 shares[14] - Wang Shi, a significant shareholder, owns 2.46% of the shares, amounting to 6,497,280 shares, with 2,980,000 shares pledged[14] - The company has a total of 2,970,600 shares held in the repurchase special securities account, representing 1.12% of the total shares[14] - As of the end of the reporting period, the total number of restricted shares held by Yan Jinyuan is 53,028,889 shares, which are subject to management lock-up[15] Government Subsidies and Other Income - The company recorded a total of CNY 3,992,414.97 in government subsidies during the reporting period, contributing to its financial performance[7] - The company received government subsidies, which increased cash inflow from operating activities by 122.06%, totaling 83,936,745.51 compared to 37,799,137.53[11] - The company reported a significant increase in cash flow from operating activities, reaching 37,761,959.61, a 195.54% improvement from -39,525,496.61[11] - The company experienced a 206.75% increase in other comprehensive income, amounting to 1,544,950.38 compared to -78,553.33 in the previous period[11] - The investment income decreased significantly by 80.67%, amounting to 1,194,804.62 compared to 6,180,237.47 in the previous period[10] Management and Governance - The company has completed the board of directors' re-election and the appointment of senior management personnel[17] - The company plans to hold its second extraordinary general meeting of 2025 on August 1, 2025, to discuss board nominations[16] - The company has not reported any changes in the shareholding structure due to the transfer of shares for margin trading[15] - The company has not disclosed any new product developments or market expansion strategies in the current report[18] - The financial statements for the quarter ending September 30, 2025, are pending publication[18]